1. Androgen receptor and FOXA1 coexpression define a “luminal-AR” subtype of feline mammary carcinomas, spontaneous models of breast cancer
   Elie Dagher et al, 2019, BMC Cancer CrossRef
2. FOXA1 Expression in Nasopharyngeal Carcinoma: Association with Clinicopathological Characteristics and EMT Markers
   Nihel Ammous-Boukhris et al, 2020, BioMed Research International CrossRef
3. FOXA1 expression in Iraqi women with ER+ breast cancer
   Iman Al-Bedairy et al, 2021, Baghdad Journal of Biochemistry and Applied Biological Sciences CrossRef
4. FOXA1 and AR in invasive breast cancer: new findings on their co-expression and impact on prognosis in ER-positive patients
   Nelson Rangel et al, 2018, BMC Cancer CrossRef
5. The transcription factor FOXA1 induces epithelial ovarian cancer tumorigenesis and progression
   Li-Li Wang et al, 2017, Tumor Biology CrossRef
6. Molecular mechanisms of the microRNA-132 during tumor progressions
   Meysam Moghbeli et al, 2021, Cancer Cell International CrossRef
7. Characterisation of male breast cancer: a descriptive biomarker study from a large patient series
   Matthew P. Humphries et al, 2017, Scientific Reports CrossRef
8. Studying GATA3, FOXA1, and ELF5 transcription factors in the evaluation of prognosis in luminal breast cancer patients
   S. V. Vtorushin et al, 2021, Bulletin of Siberian Medicine CrossRef
9. Time-varying effects of FOXA1 on breast cancer prognosis
   Qian-xin Chen et al, 2021, Breast Cancer Research and Treatment CrossRef
10. Association of FOXA1 and EMT markers (Twist1 and E-cadherin) in breast cancer
    Dorra BenAyed-Guerfali et al, 2019, Molecular Biology Reports CrossRef
11. MicroRNAs as regulators and mediators of forkhead box transcription factors function in human cancers
    Chen Li et al, 2017, Oncotarget CrossRef
12. Forkhead box proteins as the critical regulators of cisplatin response in tumor cells
    Amirhosein Maharati et al, 2023, European Journal of Pharmacology CrossRef